While the evidence is certainly lacking to recommend flexible sigmoidoscopy to the mass population, there is no reason to discourage or withhold this form of screening for healthy, asymptomatic, motivated patients while we await the results of the National Cancer Institute's primary preventive trial.
Copyright 2000